Insider Profile
Hanna, John Gordon
$HLS
1
Companies Filed At
1
Open-Market Buys (2yr)
$17K
Buy Value (2yr, open-market)
Jun 26, 2026
Most Recent Trade
Currently Accumulating Companies this insider is net-buying on the open market over the last 90 days
$HLS 60
HLS Therapeutics Inc.
$17K · 1 buy
Last buy Jun 16, 2026
Date Company Role Nature Dir. Shares Price Value Score
Jun 26, 2026 $HLS
HLS Therapeutics Inc.
— Comp. Grant Buy 50,000 $4.14 $207K 60
Jun 16, 2026 $HLS
HLS Therapeutics Inc.
— Open Market Buy 4,000 $4.30 $17K 60
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.